US Broker Ratings

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Navigating the Healthcare Sector with a Solid Revenue Growth

Pediatrix Medical Group, Inc. (NYSE: MD), a prominent player in the healthcare sector, operates within the medical care facilities industry, specializing in neonatal and pediatric medical services. With a market..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Robust Revenue Growth and Strong Buy Ratings Signal Promising Potential

Aveanna Healthcare Holdings Inc (AVAH) is capturing investor attention with its substantial market presence in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of..

NewAmsterdam Pharma (NAMS) Stock Analysis: Unlocking a 67.82% Upside Potential in Biotech

Investors exploring opportunities within the dynamic biotechnology sector might find NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS) an intriguing candidate. This Netherlands-based biopharmaceutical company, with a market cap of $3.47 billion,..

Phreesia, Inc. (PHR) Stock Analysis: Strong Buy Ratings Signal a Promising 30.54% Upside

Phreesia, Inc. (PHR) is catching the attention of investors, particularly in the healthcare technology space, with its robust SaaS-based software and payment platform tailored for the healthcare industry. With a..

Biohaven Ltd. (BHVN) Stock Analysis: Exploring a 53% Potential Upside in the Biotech Sector

For investors with a keen interest in the biotechnology sector, Biohaven Ltd. (BHVN) presents a fascinating opportunity with a significant potential upside. Headquartered in New Haven, Connecticut, Biohaven operates at..

Liquidia Corporation (LQDA) Stock Analysis: Evaluating Growth Potential Amidst Robust Revenue Surge

Investors seeking opportunities in the healthcare sector might find Liquidia Corporation (NASDAQ: LQDA) an intriguing prospect. As a biopharmaceutical company focused on developing treatments for rare cardiopulmonary diseases, Liquidia has..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Unpacking the 5.89% Potential Upside

For investors seeking opportunities in the healthcare sector, Pulse Biosciences, Inc (NASDAQ: PLSE) presents an intriguing prospect. With a market capitalization of $2 billion, this U.S.-based company operates within the..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Exploring a 121% Potential Upside with Strong Analyst Confidence

Vera Therapeutics, Inc. (NASDAQ: VERA) is making waves in the biotechnology sector with its innovative approach to treating immunological diseases. Based in Brisbane, California, this clinical-stage biotech company has a..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Exploring a 25.62% Potential Upside in the Biotech Arena

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) is capturing the attention of investors with its strategic focus on rare and orphan diseases—a niche within the biotechnology sector that holds significant promise. Headquartered..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Biotechnology Innovator with a Promising 28.63% Upside

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a trailblazer in the biotechnology sector, is capturing investor interest with its innovative approach to treating muscle disorders. With a market capitalization of $4.18 billion,..

Twist Bioscience Corporation (TWST): Investor Outlook Reveals 19.3% Revenue Growth and Strong Analyst Support

Twist Bioscience Corporation (NASDAQ: TWST), a key player in the diagnostics and research industry, continues to attract attention with its innovative synthetic DNA-based products. As the healthcare sector witnesses rapid..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A Strong Buy with 18% Potential Upside

For investors seeking exposure in the healthcare sector, Alignment Healthcare, Inc. (NASDAQ: ALHC) presents a compelling opportunity. With a robust market capitalization of $4.36 billion, this Orange, California-based company is..

Artivion, Inc. (AORT) Stock Analysis: A 65.55% Upside Potential with Strong Buy Ratings

Artivion, Inc. (AORT), a prominent player in the healthcare sector specializing in medical devices, has been capturing attention for its promising growth trajectory and compelling stock performance indicators. Headquartered in..

BioLife Solutions, Inc. (BLFS) Stock Analysis: Double-Digit Growth and Analyst Optimism Fuel Intrigue

Investors eyeing the healthcare sector would do well to look at BioLife Solutions, Inc. (NASDAQ: BLFS), a company making significant strides in the burgeoning field of cell and gene therapy..

Belite Bio, Inc (BLTE) Stock Analysis: A 37.73% Upside Potential in the Biotechnology Sector

Belite Bio, Inc (NASDAQ: BLTE), a dynamic player in the biotechnology sector, is capturing the attention of investors with its promising potential upside of 37.73%. With a market capitalization of..

Azenta, Inc. (AZTA) Stock Report: Navigating the Healthcare Sector with Strategic Partnerships

Azenta, Inc. (NASDAQ: AZTA), a prominent player in the healthcare sector, specializes in providing innovative biological and chemical compound sample management solutions for the life sciences industry. With a market..

LivaNova PLC (LIVN): Investor Outlook with 7% Upside Potential in Medical Device Innovation

LivaNova PLC (NASDAQ: LIVN), a UK-based medical technology powerhouse, has captured investor attention with its robust market presence in the healthcare sector, particularly within the medical devices industry. With a..

10x Genomics, Inc. (TXG) Stock Analysis: Healthcare Innovator with Mixed Signals and High Forward P/E

Investors with a keen eye on the healthcare sector might find 10x Genomics, Inc. (NASDAQ: TXG) an intriguing proposition. A leader in health information services, 10x Genomics operates at the..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 25.86% Potential Upside

U.S. Physical Therapy, Inc. (NYSE: USPH), a key player in the healthcare sector, stands out for its robust operations in the medical care facilities industry. With a market capitalization of..

CG Oncology, Inc. (CGON) Stock Analysis: A Promising Bet in Biotech with 28.63% Upside Potential

CG Oncology, Inc. (CGON), a burgeoning player in the biotechnology sector, is making waves with its innovative approach to tackling bladder cancer. As a late-stage clinical biopharmaceutical company, CG Oncology..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds